# Mondelez International, Inc.: financial statements, quarterly

MDLZ · Nasdaq · CIK 1103982 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdlz.md) · [Financials](/companies/mdlz/financials.md) · [Filings](/companies/mdlz/filings.md) · [Insiders](/companies/mdlz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mdlz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.3 d](/filings/0001628280-26-005345.md) | [9.3](/filings/0001103982-25-000127.md) | [8.3](/filings/0001103982-25-000188.md) | [9.2](/filings/0001628280-25-046773.md) | [9.6 d](/filings/0001628280-26-005345.md) | [9.3](/filings/0001628280-26-027937.md) | [9.0](/filings/0001628280-26-050179.md) | [9.7](/filings/0001628280-26-068256.md) | [10.5 d](/filings/0001628280-26-005345.md) | [10.1](/filings/0001628280-26-027937.md) | [9.4](/filings/0001628280-26-050179.md) | [10.0](/filings/0001628280-26-068256.md) |
| Cost of revenue | $bn | [5.8 d](/filings/0001628280-26-005345.md) | [4.5](/filings/0001103982-25-000127.md) | [5.5](/filings/0001103982-25-000188.md) | [6.2](/filings/0001628280-25-046773.md) | [5.9 d](/filings/0001628280-26-005345.md) | [6.9](/filings/0001628280-26-027937.md) | [6.0](/filings/0001628280-26-050179.md) | [7.1](/filings/0001628280-26-068256.md) | [7.5 d](/filings/0001628280-26-005345.md) | [7.3](/filings/0001628280-26-027937.md) | [5.4](/filings/0001628280-26-050179.md) | [6.0](/filings/0001628280-26-068256.md) |
| Gross profit | $bn | [3.5 d](/filings/0001628280-26-005345.md) | [4.8](/filings/0001103982-25-000127.md) | [2.8](/filings/0001103982-25-000188.md) | [3.0](/filings/0001628280-25-046773.md) | [3.7 d](/filings/0001628280-26-005345.md) | [2.4](/filings/0001628280-26-027937.md) | [2.9](/filings/0001628280-26-050179.md) | [2.6](/filings/0001628280-26-068256.md) | [3.0 d](/filings/0001628280-26-005345.md) | [2.8](/filings/0001628280-26-027937.md) | [4.0](/filings/0001628280-26-050179.md) | [3.9](/filings/0001628280-26-068256.md) |
| Selling, general and administrative | $bn | [2.3 d](/filings/0001628280-26-005345.md) | [1.9](/filings/0001103982-25-000127.md) | [1.9](/filings/0001103982-25-000188.md) | [1.6](/filings/0001628280-25-046773.md) | [2.0 d](/filings/0001628280-26-005345.md) | [1.7](/filings/0001628280-26-027937.md) | [1.7](/filings/0001628280-26-050179.md) | [1.8](/filings/0001628280-26-068256.md) | [1.9 d](/filings/0001628280-26-005345.md) | [1.9](/filings/0001628280-26-027937.md) | [2.0](/filings/0001628280-26-050179.md) | [2.0](/filings/0001628280-26-068256.md) |
| Operating income | $bn | [1.2 d](/filings/0001628280-26-005345.md) | [2.7](/filings/0001103982-25-000127.md) | [0.9](/filings/0001103982-25-000188.md) | [1.2](/filings/0001628280-25-046773.md) | [1.6 d](/filings/0001628280-26-005345.md) | [0.7](/filings/0001628280-26-027937.md) | [1.2](/filings/0001628280-26-050179.md) | [0.7](/filings/0001628280-26-068256.md) | [1.0 d](/filings/0001628280-26-005345.md) | [0.8](/filings/0001628280-26-027937.md) | [1.9](/filings/0001628280-26-050179.md) | [1.8](/filings/0001628280-26-068256.md) |
| Income tax | $bn | [0.3 d](/filings/0001628280-26-005345.md) | [0.6](/filings/0001103982-25-000127.md) | [0.3](/filings/0001103982-25-000188.md) | [0.3](/filings/0001628280-25-046773.md) | [0.2 d](/filings/0001628280-26-005345.md) | [0.2](/filings/0001628280-26-027937.md) | [0.2](/filings/0001628280-26-050179.md) | [0.1](/filings/0001628280-26-068256.md) | [0.3 d](/filings/0001628280-26-005345.md) | [0.2](/filings/0001628280-26-027937.md) | [0.4](/filings/0001628280-26-050179.md) | [0.4](/filings/0001628280-26-068256.md) |
| Net income | $bn | [1.0 d](/filings/0001628280-26-005345.md) | [1.4](/filings/0001103982-25-000127.md) | [0.6](/filings/0001103982-25-000188.md) | [0.9](/filings/0001628280-25-046773.md) | [1.7 d](/filings/0001628280-26-005345.md) | [0.4](/filings/0001628280-26-027937.md) | [0.6](/filings/0001628280-26-050179.md) | [0.7](/filings/0001628280-26-068256.md) | [0.7 d](/filings/0001628280-26-005345.md) | [0.6](/filings/0001628280-26-027937.md) | [1.5](/filings/0001628280-26-050179.md) | [1.3](/filings/0001628280-26-068256.md) |
| Diluted EPS | $ per share | not reported | [1.04](/filings/0001103982-25-000127.md) | [0.45](/filings/0001103982-25-000188.md) | [0.63](/filings/0001628280-25-046773.md) | not reported | [0.31](/filings/0001628280-26-027937.md) | [0.49](/filings/0001628280-26-050179.md) | [0.57](/filings/0001628280-26-068256.md) | not reported | [0.44](/filings/0001628280-26-027937.md) | [1.20](/filings/0001628280-26-050179.md) | [1.02](/filings/0001628280-26-068256.md) |
| Basic EPS | $ per share | not reported | [1.05](/filings/0001103982-25-000127.md) | [0.45](/filings/0001103982-25-000188.md) | [0.64](/filings/0001628280-25-046773.md) | not reported | [0.31](/filings/0001628280-26-027937.md) | [0.49](/filings/0001628280-26-050179.md) | [0.57](/filings/0001628280-26-068256.md) | not reported | [0.44](/filings/0001628280-26-027937.md) | [1.21](/filings/0001628280-26-050179.md) | [1.02](/filings/0001628280-26-068256.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [11.7](/filings/0001103982-25-000030.md) | [19.4](/filings/0001103982-24-000055.md) | [15.2](/filings/0001103982-24-000092.md) | [13.2](/filings/0001103982-24-000104.md) | [13.2](/filings/0001628280-26-005345.md) | [12.7](/filings/0001103982-25-000127.md) | [12.8](/filings/0001103982-25-000188.md) | [13.1](/filings/0001628280-25-046773.md) | [13.0](/filings/0001628280-26-068256.md) | [12.7](/filings/0001628280-26-027937.md) | [12.9](/filings/0001628280-26-050179.md) | [13.8](/filings/0001628280-26-068256.md) |
| Total assets | $bn | [71.4](/filings/0001103982-25-000030.md) | [77.6](/filings/0001103982-24-000055.md) | [73.1](/filings/0001103982-24-000092.md) | [72.2](/filings/0001103982-24-000104.md) | [68.5](/filings/0001628280-26-005345.md) | [68.9](/filings/0001103982-25-000127.md) | [71.0](/filings/0001103982-25-000188.md) | [71.4](/filings/0001628280-25-046773.md) | [71.5](/filings/0001628280-26-068256.md) | [71.1](/filings/0001628280-26-027937.md) | [71.2](/filings/0001628280-26-050179.md) | [71.8](/filings/0001628280-26-068256.md) |
| Current liabilities | $bn | [19.0](/filings/0001103982-25-000030.md) | [25.3](/filings/0001103982-24-000055.md) | [22.4](/filings/0001103982-24-000092.md) | [21.1](/filings/0001103982-24-000104.md) | [19.5](/filings/0001628280-26-005345.md) | [21.0](/filings/0001103982-25-000127.md) | [19.9](/filings/0001103982-25-000188.md) | [21.5](/filings/0001628280-25-046773.md) | [21.9](/filings/0001628280-26-068256.md) | [23.5](/filings/0001628280-26-027937.md) | [21.6](/filings/0001628280-26-050179.md) | [22.4](/filings/0001628280-26-068256.md) |
| Total liabilities | $bn | [43.0](/filings/0001103982-25-000030.md) | [49.1](/filings/0001103982-24-000055.md) | [45.4](/filings/0001103982-24-000092.md) | [44.3](/filings/0001103982-24-000104.md) | [41.5](/filings/0001628280-26-005345.md) | [43.1](/filings/0001103982-25-000127.md) | [44.8](/filings/0001103982-25-000188.md) | [45.1](/filings/0001628280-25-046773.md) | [45.6](/filings/0001628280-26-068256.md) | [45.3](/filings/0001628280-26-027937.md) | [44.6](/filings/0001628280-26-050179.md) | [45.1](/filings/0001628280-26-068256.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.4](/filings/0001103982-25-000030.md) | [0.3](/filings/0001103982-24-000055.md) | [0.8](/filings/0001103982-24-000092.md) | [1.5](/filings/0001103982-24-000104.md) | [0.1](/filings/0001628280-26-005345.md) | [1.9](/filings/0001103982-25-000127.md) | [1.7](/filings/0001103982-25-000188.md) | [2.6](/filings/0001628280-25-046773.md) | [2.7](/filings/0001628280-26-068256.md) | [2.9](/filings/0001628280-26-027937.md) | [2.3](/filings/0001628280-26-050179.md) | [3.7](/filings/0001628280-26-068256.md) |
| Shareholders' equity | $bn | [28.3](/filings/0001103982-25-000030.md) | [28.5](/filings/0001103982-24-000055.md) | [27.7](/filings/0001103982-24-000092.md) | [27.9](/filings/0001103982-24-000104.md) | [26.9](/filings/0001628280-26-005345.md) | [25.8](/filings/0001103982-25-000127.md) | [26.2](/filings/0001103982-25-000188.md) | [26.2](/filings/0001628280-25-046773.md) | [25.8](/filings/0001628280-26-068256.md) | [25.8](/filings/0001628280-26-027937.md) | [26.6](/filings/0001628280-26-050179.md) | [26.6](/filings/0001628280-26-068256.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,564 d](/filings/0001628280-26-005345.md) | [1,324](/filings/0001103982-25-000127.md) | [822 d](/filings/0001103982-25-000188.md) | [1,305 d](/filings/0001628280-25-046773.md) | [1,459 d](/filings/0001628280-26-005345.md) | [1,092](/filings/0001628280-26-027937.md) | [308 d](/filings/0001628280-26-050179.md) | [717 d](/filings/0001628280-26-068256.md) | [2,397 d](/filings/0001628280-26-005345.md) | [467](/filings/0001628280-26-027937.md) | [855 d](/filings/0001628280-26-050179.md) | [1,284 d](/filings/0001628280-26-068256.md) |
| Capital expenditure | $m | [332 d](/filings/0001628280-26-005345.md) | [299](/filings/0001103982-25-000127.md) | [367 d](/filings/0001103982-25-000188.md) | [316 d](/filings/0001628280-25-046773.md) | [405 d](/filings/0001628280-26-005345.md) | [277](/filings/0001628280-26-027937.md) | [305 d](/filings/0001628280-26-050179.md) | [299 d](/filings/0001628280-26-068256.md) | [398 d](/filings/0001628280-26-005345.md) | [312](/filings/0001628280-26-027937.md) | [342 d](/filings/0001628280-26-050179.md) | [293 d](/filings/0001628280-26-068256.md) |
| Dividends paid | $m | [579 d](/filings/0001628280-26-005345.md) | [578](/filings/0001103982-25-000127.md) | [573 d](/filings/0001103982-25-000188.md) | [571 d](/filings/0001628280-25-046773.md) | [627 d](/filings/0001628280-26-005345.md) | [623](/filings/0001628280-26-027937.md) | [610 d](/filings/0001628280-26-050179.md) | [609 d](/filings/0001628280-26-068256.md) | [645 d](/filings/0001628280-26-005345.md) | [644](/filings/0001628280-26-027937.md) | [643 d](/filings/0001628280-26-050179.md) | [640 d](/filings/0001628280-26-068256.md) |
| Share repurchases | $m | [888 d](/filings/0001628280-26-005345.md) | [568](/filings/0001103982-25-000127.md) | [506 d](/filings/0001103982-25-000188.md) | [113 d](/filings/0001628280-25-046773.md) | [1,147 d](/filings/0001628280-26-005345.md) | [1,522](/filings/0001628280-26-027937.md) | [131 d](/filings/0001628280-26-050179.md) | [240 d](/filings/0001628280-26-068256.md) | [492 d](/filings/0001628280-26-005345.md) | [0.0](/filings/0001628280-26-027937.md) | [212 d](/filings/0001628280-26-050179.md) | [633 d](/filings/0001628280-26-068256.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,373](/filings/0001103982-24-000055.md) | [1,372](/filings/0001103982-24-000092.md) | [1,370](/filings/0001103982-24-000104.md) | [1,355](/filings/0001103982-25-000127.md) | [1,348](/filings/0001103982-25-000188.md) | [1,344](/filings/0001628280-25-046773.md) | [1,305](/filings/0001628280-26-027937.md) | [1,299](/filings/0001628280-26-050179.md) | [1,296](/filings/0001628280-26-068256.md) | [1,286](/filings/0001628280-26-027937.md) | [1,287](/filings/0001628280-26-050179.md) | [1,280](/filings/0001628280-26-068256.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,265,838,379 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068256.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:12 ET. No prices; not investment advice.